Cytosurge Inc. This revolutionary technology offers precise injections and extractions across a wide range of cell types and applications, all while maintaining cell viability. With the FluidFM OMNIUM instrument and the CellEDIT service, Cytosurge enables researchers to go beyond in single-cell manipulation.

Their solutions include CRISPR gene editing, single-cell profiling, and mechanobiology, allowing scientists to uncover the potential use of FluidFM in temporal transcriptomics and precision genome engineering. Cytosurge offers two ways to work with them: the FluidFM OMNIUM instrument for versatile and semi-automated single-cell manipulation, and the CellEDIT service for complex edits in CRISPR cell line editing. With a vast knowledge center, numerous publications, and an insightful blog, Cytosurge provides researchers with the necessary resources to advance their understanding of FluidFM.

Cytosurge's technology has gained tremendous momentum globally, with leading scientists applauding its high adaptability and potential in various fields, including epigenetics and microbiology. Cytosurge's ultimate goal is to empower genetic engineers to create next-generation gene-edited mammalian cell lines and revolutionize therapy manufacturing. With their innovative solutions, Cytosurge is redefining the boundaries of what's possible in single-cell manipulation